Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Simbiosys Inc. has a focused prosecution profile with 1 pending office action in the Medical Devices & Mechanical Engineering technology area. This single action is assigned to 1 distinct examiner, MOHAMMED, SHAHDEEP, who is the busiest examiner with 1 pending office action. The matter is located within 1 distinct art unit, representing the entirety of the company's current active filings. The outcome of this case will determine the immediate success of the company's patent efforts.
Because there is only 1 pending office action, the company's immediate success in this technology area depends on the review of MOHAMMED, SHAHDEEP. The concentration within 1 distinct art unit and under 1 distinct examiner means that the prosecution strategy is highly localized. Practitioners should focus entirely on the specific requirements of this examiner to advance the application. With 1 pending office action, the applicant can dedicate all resources to addressing the feedback from the 1 distinct art unit involved.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MOHAMMED, SHAHDEEP | 1 | 51.7% | +56.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19136095 | MULTI-TISSUE SEGMENTATION AND DEFORMATION FOR BREAST CANCER SURGERY | MOHAMMED, SHAHDEEP | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19136095 | MULTI-TISSUE SEGMENTATION AND DEFORMATION FOR BREAST CANCER SURGERY | MOHAMMED, SHAHDEEP | — |
| Art Unit | Apps |
|---|---|
| 3797 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19136095 | MULTI-TISSUE SEGMENTATION AND DEFORMATION FOR BREAST CANCER SURGERY | MOHAMMED, SHAHDEEP | 3797 | §101§103§112 | Non-Final OA | — | Pending | Jun 05, 2025 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialSimbiosys Inc. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Shahdeep Mohammed has the most, with 1 of Simbiosys Inc.'s pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
